Ö. F. TURAN Et Al. , "Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy," Elsevier BV , vol.2, 2022
TURAN, Ö. F. Et Al. 2022. Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy. Elsevier BV , vol.2 .
TURAN, Ö. F., KÖSEOĞLU, M., & KOÇ, E. R., (2022). Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy. Elsevier BV , vol.2.
TURAN, ÖMER, MESRURE KÖSEOĞLU, And EMİNE RABİA KOÇ. "Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy," Elsevier BV , vol.2, 2022
TURAN, ÖMER F. Et Al. "Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy." Elsevier BV , vol.2, 2022
TURAN, Ö. F. KÖSEOĞLU, M. And KOÇ, E. R. (2022) . "Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy." Elsevier BV , vol.2.
@article{article, author={ÖMER FARUK TURAN Et Al. }, title={Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy}, journal={Elsevier BV}, year=2022}